Celsion Corporation (CLSN) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the tape, currently trading at $3.89, up from yesterday’s close by 1.57%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.
No amount of research is complete without a bird’s eye view of the financial data. Celsion Corporation (CLSN) currently trades with a market capitalization of $40.30 Million.
The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For CLSN, the company currently has $3.63 Million of cash on the books. You can get a sense of how sustainable that is by a levered free cash flow of $-16.76 Million over the past twelve months. Generally speaking, earnings are expected to grow in coming quarters. Analysts are forecasting earnings of $-0.43 on a per share basis this quarter. Perhaps, that suggests something about why 16.73% of the outstanding share supply is held by institutional investors.
As most professionals know, technical analysis can offer critical insights into what smart money and insiders think about a stock’s prospects going forward. Looking at the stock’s movement on the chart, Celsion Corporation recorded a 52-week high of $16.38. It is now trading 12.49% off that level. The stock is trading $2.12 its 50-day moving average by -1.77%. The stock carved out a 52-week low down at $1.24.
In recent action, Celsion Corporation (CLSN) has made a move of +159.33% over the past month, which has come on Strong relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 19.52, and it’s gotten there by action that has been less volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 10.51% with $7.32 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of CLSN.